Swiss National Bank
DFTX

Swiss National Bank’s Definium Therapeutics DFTX Stock Holding History

Swiss National Bank’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.99M Hold
158,400
– – ﹤0.01% 1639
2025
Q4 		$2.12M Buy
158,400
+41,300
+35% +$511K ﹤0.01% 1842
2025
Q3 		$1.38M Buy
117,100
+2,000
+2% +$18.7K ﹤0.01% 2021
2025
Q2 		$747K Buy
115,100
+8,500
+8% +$55.9K ﹤0.01% 2242
2025
Q1 		$624K Sell
106,600
-13,300
-11% -$95.3K ﹤0.01% 2302
2024
Q4 		$835K Hold
119,900
– – ﹤0.01% 2283
2024
Q3 		$682K Buy
119,900
+9,000
+8% +$62.6K ﹤0.01% 2357
2024
Q2 		$800K Buy
+110,900
New +$970K ﹤0.01% 2271
2022
Q4 		– Sell
-56,560
Closed -$198K – 2707
2022
Q3 		$198K Hold
56,560
– – ﹤0.01% 2693
2022
Q2 		$539K Sell
56,560
-6,847
-11% -$86.6K ﹤0.01% 2595
2022
Q1 		$1.08M Buy
63,407
+11,887
+23% +$206K ﹤0.01% 2372
2021
Q4 		$1.05M Buy
51,520
+3,753
+8% +$120K ﹤0.01% 2448
2021
Q3 		$1.72M Hold
47,767
– – ﹤0.01% 2147
2021
Q2 		$2.5M Buy
+47,767
New +$2.51M ﹤0.01% 1959

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Swiss National Bank's DFTX Position: Q1 2026 in Review

Swiss National Bank held its Definium Therapeutics (DFTX) position steady in Q1 2026 at 158,400 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1639.

Swiss National Bank first reported a position in DFTX in Q2 2021 and has held it in 14 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Swiss National Bank held 158,400 shares of Definium Therapeutics worth $2.99M as of Q1 2026.
  • Swiss National Bank left its Definium Therapeutics share count unchanged in Q1 2026.
  • Definium Therapeutics made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1639 holding.
  • Swiss National Bank first reported a position in Definium Therapeutics in Q2 2021 and has held it in 14 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.